- Home
- GRX vs ASMB Comparison
GRX vs ASMB Comparison
Compare GRX & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- ASMB
- Stock Information
- Founded
- GRX 2007
- ASMB 2005
- Country
- GRX United States
- ASMB United States
- Employees
- GRX N/A
- ASMB N/A
- Industry
- GRX Finance/Investors Services
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- ASMB Health Care
- Exchange
- GRX Nasdaq
- ASMB Nasdaq
- Market Cap
- GRX 148.5M
- ASMB 130.2M
- IPO Year
- GRX N/A
- ASMB 2010
- Fundamental
- Price
- GRX $9.57
- ASMB $17.80
- Analyst Decision
- GRX
- ASMB Strong Buy
- Analyst Count
- GRX 0
- ASMB 3
- Target Price
- GRX N/A
- ASMB $33.00
- AVG Volume (30 Days)
- GRX 39.7K
- ASMB 36.8K
- Earning Date
- GRX 01-01-0001
- ASMB 08-07-2025
- Dividend Yield
- GRX 5.98%
- ASMB N/A
- EPS Growth
- GRX N/A
- ASMB N/A
- EPS
- GRX 0.26
- ASMB N/A
- Revenue
- GRX N/A
- ASMB $32,154,000.00
- Revenue This Year
- GRX N/A
- ASMB $0.04
- Revenue Next Year
- GRX N/A
- ASMB N/A
- P/E Ratio
- GRX $38.50
- ASMB N/A
- Revenue Growth
- GRX N/A
- ASMB 148.33
- 52 Week Low
- GRX $7.73
- ASMB $7.75
- 52 Week High
- GRX $10.40
- ASMB $19.93
- Technical
- Relative Strength Index (RSI)
- GRX 49.33
- ASMB 75.21
- Support Level
- GRX $9.39
- ASMB $16.50
- Resistance Level
- GRX $9.69
- ASMB $17.94
- Average True Range (ATR)
- GRX 0.13
- ASMB 0.76
- MACD
- GRX 0.00
- ASMB -0.02
- Stochastic Oscillator
- GRX 44.46
- ASMB 90.22
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.